Unique ID issued by UMIN | UMIN000016531 |
---|---|
Receipt number | R000019145 |
Scientific Title | A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy. |
Date of disclosure of the study information | 2015/02/13 |
Last modified on | 2018/08/17 10:14:45 |
A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy.
A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy.
A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy.
A safety and efficacy exploratory study of daikenchuto to relieve abdominal bloating in patients who has been ileostomy.
Japan |
Ileostomy patients with abdominal bloating
Gastroenterology | Gastrointestinal surgery |
Others
NO
The purpose of this study is to determine whether daikenchuto is effective and safe in the treatment of abdominal bloating who has been ileostomy.
Safety,Efficacy
1)Abdominal bloating
2)Gastrointestinal symptom rating scale(GSRS)
3)Analysis of ileostomy effluent
-intestinal flora
-organic acid
-pH
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Taking Daokenchuto 15g/day orally for 4 weeks.
20 | years-old | <= |
Not applicable |
Male and Female
1)Patients who has been ileostomy
2)Patients with abdominal bloating
3)Age: more than or equal to 20 years at the time of providing informed consent
4)Patients are male or female
5)Patients are in patients or out patients
6)Patients have ileotoma.
7)Provide written informed consent
1)Patients with strangulating intestinal obstruction.
2)Patients who are administrated preparation for viable organism within 4 weeks before this study.
3)Patients who was administrated daikenchuto or any Japanese traditional herbal medicine within 4 weeks before this study
4)Virus-positive (HIV, HBV, HCN)
5)Patients have serious coexisting disease (ex. Hepatic distorder, kidney disorder, cardiac disorder, hematological disorder, or metabolic disorder)
6)Women who was lactating or pregnant or person who hope the pregnancy of the partne.
7)Unsuitability as determined by the study doctor
10
1st name | |
Middle name | |
Last name | Toru Kono |
Sapporo Higashi Tokushukai Hospital
Center for Clinical and Biomedical Research
3-1, Kita 33-jo Higashi 14-chome, Higashi-ku, Sapporo
011-722-1110
kono@toru-kono.com
1st name | |
Middle name | |
Last name | Toru Kono |
Sapporo Higashi Tokushukai Hospital
Center for Clinical and Biomedical Research
3-1, Kita 33-jo Higashi 14-chome, Higashi-ku, Sapporo
011-722-1110
kono@toru-kono.com
Sapporo Higashi Tokushukai Hospital Center for Clinical and Biomedical Research
TSUMURA & CO.
Profit organization
NO
2015 | Year | 02 | Month | 13 | Day |
Unpublished
Completed
2014 | Year | 10 | Month | 20 | Day |
2015 | Year | 02 | Month | 16 | Day |
2015 | Year | 02 | Month | 13 | Day |
2018 | Year | 08 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019145